Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response
2005

Laser Therapy and Immune Response in Tumor Treatment

Sample size: 288 publication Evidence: high

Author Information

Author(s): Ivarsson K, Myllymäki L, Jansner K, Stenram U, Tranberg K-G

Primary Institution: Lund University

Hypothesis

Does interstitial laser thermotherapy (ILT) induce a cellular immune response that can resist tumor challenges?

Conclusion

Interstitial laser thermotherapy effectively eradicates challenging tumors and is associated with an increased immune response.

Supporting Evidence

  • Rats treated with ILT showed eradication of challenging tumors and no evidence of tumor spread.
  • Significantly higher numbers of macrophages and CD8 lymphocytes were found in ILT-treated rats compared to those that underwent resection.
  • ILTs induced a strong immune response that persisted for at least 10 weeks after treatment.

Takeaway

This study shows that a special laser treatment can help the body fight tumors better by making the immune system stronger.

Methodology

Male rats with implanted tumors were treated with either ILT or surgical resection, followed by tumor challenges at various intervals to assess immune response.

Potential Biases

The use of a long-established tumor model may introduce bias related to transplantation antigens.

Limitations

The study used a syngeneic tumor model, which may not fully represent human tumors due to potential genetic drift over time.

Participant Demographics

Male rats weighing 224–292 g were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602718

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication